We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
4801
Autolus Therapeutics
AUTL
$386M
-32,500
Closed -$216K
AXSM icon
4802
PUT
Axsome Therapeutics
AXSM
$12.4B
-20,800
Closed -$1.4M
FABC
4803
Fabric.AI Inc
FABC
$16.8M
-141
Closed -$88K
BBD icon
4804
Banco Bradesco
BBD
$38.1B
-23,810
Closed -$94.9K
BBY icon
4805
PUT
Best Buy
BBY
$18B
-18,000
Closed -$2.07M
BEN icon
4806
Franklin Resources
BEN
$16.9B
-28,136
Closed -$878K
BHC icon
4807
Bausch Health
BHC
$1.65B
-160,491
Closed -$4.55M
BKH icon
4808
Black Hills Corp
BKH
$5.73B
-3,375
Closed -$222K
BKR icon
4809
Baker Hughes
BKR
$56.8B
-16,014
Closed -$357K
BLK icon
4810
PUT
Blackrock
BLK
$164B
-22,900
Closed -$20M
BLNK icon
4811
Blink Charging
BLNK
$75.2M
-44,108
Closed -$1.82M
BMA icon
4812
PUT
Banco Macro
BMA
$5.7B
-93,700
Closed -$1.41M
BNGO icon
4813
Bionano Genomics
BNGO
$12.7M
-18
Closed -$81K
BR icon
4814
Broadridge
BR
$17.2B
-18,656
Closed -$3.01M
BRFS
4815
DELISTED
BRF SA
BRFS
-49,143
Closed -$269K
BTI icon
4816
British American Tobacco
BTI
$132B
-1,180,526
Closed -$46.4M
BUD icon
4817
AB InBev
BUD
$158B
-31,761
Closed -$1.99M
BWXT icon
4818
BWX Technologies
BWXT
$16B
-57,652
Closed -$3.35M
BXC icon
4819
BlueLinx
BXC
$455M
-46,658
Closed -$2.35M
BBBY
4820
CALL
Bed Bath & Beyond
BBBY
$473M
-22,990
Closed -$1.93M
BZH icon
4821
CALL
Beazer Homes USA
BZH
$907M
-37,100
Closed -$716K
CAAP icon
4822
Corporacion America
CAAP
$4.11B
-21,487
Closed -$123K
CADE
4823
DELISTED
Cadence Bank
CADE
-166,064
Closed -$4.71M
CAMT icon
4824
Camtek
CAMT
$6.9B
-6,801
Closed -$256K
CARE icon
4825
Carter Bankshares
CARE
$756M
-37,892
Closed -$474K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.